Article Data

  • Views 647
  • Dowloads 118

Case Reports

Open Access

Uterine mullerian adenosarcoma in very young patient

  • Tajossadat Allameh1,*,
  • Elham Naghshineh1
  • Leila Mousavi Seresht2
  • Parvin Rajabi3
  • Narges Izadi-Mood4

1Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3Professor of pathology, Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4Professor of pathology, Department of Pathology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

DOI: 10.31083/j.ejgo.2020.05.5372 Vol.41,Issue 5,October 2020 pp.817-820

Submitted: 10 September 2019 Accepted: 28 October 2019

Published: 15 October 2020

*Corresponding Author(s): Tajossadat Allameh E-mail: tallameh@med.mui.ac.ir.

Abstract

Introduction: Uterine adenosarcoma mostly seen in elderly and there are limited data on appropriate approach in premenopausal patient and the accurate prognosis. Herein we aimed to present a young case of Müllerian adenosarcoma of uterus which had only 9 years old. Case report: A 9year old pre pubertal girl presented to the gynecology department of Isfahan University of Medical Sciences-Iran with the vaginal bleeding. An intrauterine mass was noted via hysteroscopic examination as the reason of abnormal bleeding. The final pathology revealed Müllerian adenosarcoma of uterus. Subsequently hysterectomy was done due to persistent perfused vaginal bleeding; with ovarian preservation. Conclusion: Due to rarity of Müllerian adenosarcoma, the gynecologists and pathologists should be reminded about the possibility of the diagnosis in young patients too.


Keywords

Müllerian adenosarcoma; Uterine; Mesenchymal tumor; Childhood; Vaginal bleeding; Adolescent.


Cite and Share

Tajossadat Allameh,Elham Naghshineh,Leila Mousavi Seresht,Parvin Rajabi,Narges Izadi-Mood. Uterine mullerian adenosarcoma in very young patient. European Journal of Gynaecological Oncology. 2020. 41(5);817-820.

References

[1] Wu R.I., Schorge J.O., Cin P.D., Young R.H., Oliva E.: “Müllerian adenosarcoma of the uterus with low-grade sarcomatous overgrowth characterized by prominent hydropic change resulting in mimicry of a smooth muscle tumor”. Int. J. Gynecol. Pathol., 2014, 33, 573.

[2] Nasioudis D., Chapman-Davis E., Frey M., Holcomb K.: “Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma”. J. gynecol. oncol. 2017, 19, 28.

[3] Patrelli T.S., Gizzo S., Di Gangi S., Guidi G., Rondinelli M., Nardelli G. B.: “Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature”. BMC Cancer, 2011, 11, 236.

[4] Goh C., Lin X.H., Chin P.S., Lim Y.K.: “Uterine preservation in a young patient with adenosarcoma of the uterus–Case report and review of literature”. Gynecol. Oncol.Rep., 2018, 25, 27.

[5] Lee Y., Kim D., Suh D., Kim J., Kim Y., Kim Y., et al.: “Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience”. World J. Surg. oncol., 2017, 15, 87.

[6] Yoon A., Park J.Y., Park J.Y., Lee Y.Y., Kim T.J., Choi C.H., et al.: “Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases”. Gynecol. Oncol., 2014, 132, 70.

[7] Li N., Wu L.Y., Zhang H.T., An J.S., Li X.G., Ma S.K.: “Treatment options in stage I endometrial stromal sarcoma: a retrospective analysis of 53 cases”. Gynecol. Oncol., 2008, 108, 306.

[8] Sangle N.A., Lele S.M.: “Uterine mesenchymal tumors”. Indian J. Pathol. Microbiol., 2011, 54, 243.

[9] Ramos P., Ruiz A., Carabias E., Piñero I., Garzon A., Alvarez I.: “Mül-lerian adenosarcoma of the cervix with heterologous elements: report of a case and review of the literature”. Gynecol. oncol., 2002, 84, 161.

[10] Morales F.D.A., Medina R.M.L., Trujillo L.M., Beltrán M.I., Dulcey I.C.: “Müllerian adenosarcoma of the uterine cervix with sarcomatous overgrowth: A case report of aggressive disease in a young patient”. Int.J. Sur. Case Rep., 2016, 27, 155.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top